Quantifying the allosteric interactions within a G-protein-coupled receptor heterodimer.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Drug Discovery Today

• Publication date

  Unknown publication date

• Fields of study

  Biology, Mathematics, Medicine

• Identifiers
  DOI 10.1016/j.drudis.2017.07.009PMID 28756203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers

  2017cited by this paper
• Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area

  2017cited by this paper
• Theoretical Aspects of GPCR-Ligand Complex Pharmacology.

  2017cited by this paper
• Angiotensin II type 1/adenosine A2A receptor oligomers: a novel target for tardive dyskinesia

  2017cited by this paper
• Allosteric modulation as a unifying mechanism for receptor function and regulation

  2017cited by this paper
• Have many estimates of efficacy and affinity been misled? Revisiting the operational model of agonism.

  2016cited by this paper
• Mechanism of Assembly and Cooperativity of Homomeric and Heteromeric Metabotropic Glutamate Receptors.

  2016cited by this paper
• Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

  2016cited by this paper
• A comprehensive map of molecular drug targets

  2016cited by this paper
• Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation.

  2016cited by this paper
• Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer

  2015cited by this paper
• Functional studies cast light on receptor states.

  2015cited by this paper
• Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors

  2015cited by this paper
• The chemokine CXC4 and CC2 receptors form homo‐ and heterooligomers that can engage their signaling G‐protein effectors and βarrestin

  2014cited by this paper
• G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives

  2014cited by this paper
• Application of receptor theory to allosteric modulation of receptors.

  2013cited by this paper
• G protein-coupled receptor heterocomplexes in neuropsychiatric disorders.

  2013cited by this paper
• Multiple active receptor conformation, agonist efficacy and maximum effect of the system: the conformation-based operational model of agonism.

  2013cited by this paper
• Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two‐state and operational models

  2013cited by this paper
• Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4

  2012cited by this paper
• A simple method for quantifying functional selectivity and agonist bias.

  2012cited by this paper
• A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors

  2011cited by this paper
• The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways.

  2010cited by this paper
• Evidence for Distinct Antagonist-Revealed Functional States of 5-Hydroxytryptamine2A Receptor Homodimers

  2009cited by this paper
• Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system

  2009cited by this paper
• G‐protein‐coupled receptor heteromers: function and ligand pharmacology

  2008cited by this paper
• Modeling the Binding and Function of Metabotropic Glutamate Receptors

  2008cited by this paper
• Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.

  2007cited by this paper
• Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation.

  2000cited by this paper
• Operational models of pharmacological agonism

  1983cited by this paper

• Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model.

  2024cites this paper
• Allosteric binding cooperativity in a kinetic context.

  2022cites this paper
• Analysis of the Function of Receptor Oligomers by Operational Models of Agonism

  2021cites this paper
• P 28A photoswitchable antimetabolite for targeted photoactivated chemotherapy

  2018cites this paper